Literature DB >> 10976833

Reliability of sweat-testing by the Macroduct collection method combined with conductivity analysis in comparison with the classic Gibson and Cooke technique.

G Mastella1, G Di Cesare, A Borruso, L Menin, L Zanolla.   

Abstract

UNLABELLED: This study was to ascertain the reliability of sweat-testing by the Macroduct collection method combined with conductivity analysis (MCS) compared with the Gibson and Cooke technique (GCT). Sweat stimulation by pilocarpine iontophoresis was identical for both procedures, sweat being collected for 30 min on a filter paper on one forearm and in the coil of the Macroduct collector on the other. Chloride, sodium and potassium concentrations were chemically analysed both on paper-eluted and tube-collected sweat; the latter was also analysed using a conductivity analyser. Chemical analyses were compared with conductivity analyses. This prospective study was carried out on 318 subjects with MCS (118 CFs, 200 controls) and on 305 of them with the GCT (113 CFs, 192 controls). The pilocarpine iontophoresis produced adequate sweat in 96.4% of collections with GCT and in 90.9% with the MCS. Sensitivity and specificity of the Macroduct/conductivity system were comparable to the GCT. No patient detected by the GCT technique was considered negative by conductivity, but one GCT positive was "borderline" with the MCS. Six non-CF subjects identified as negative by the GCT (3.3%) were in the borderline range with the MCS.
CONCLUSION: Sweat-testing by the MCS has acceptable sensitivity and specificity when performed by trained CF sweat-testing technicians. Additional studies will be required to find out if these results can be confirmed in small clinics and hospitals where testing is done infrequently. Wherever the MCS is used all positive or borderline results should be confirmed by the GCT at a reference Cystic Fibrosis Center.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10976833     DOI: 10.1080/080352500750043378

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  14 in total

1.  Australian guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis: report from the AACB Sweat Testing Working Party.

Authors:  John Coakley; Sue Scott; James Doery; Ronda Greaves; Peter Talsma; Elaine Whitham; Janet Winship
Journal:  Clin Biochem Rev       Date:  2006-05

2.  Sweat testing in CF.

Authors:  Lutz Naehrlich
Journal:  Thorax       Date:  2007-05       Impact factor: 9.139

3.  The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era.

Authors:  Avantika Mishra; Ronda Greaves; John Massie
Journal:  Clin Biochem Rev       Date:  2005-11

4.  Australasian Guideline (2nd Edition): an Annex to the CLSI and UK Guidelines for the Performance of the Sweat Test for the Diagnosis of Cystic Fibrosis.

Authors:  John Massie; Ronda Greaves; Michael Metz; Veronica Wiley; Peter Graham; Samantha Shepherd; Richard Mackay
Journal:  Clin Biochem Rev       Date:  2017-11

5.  Nanoduct sweat testing for rapid diagnosis in newborns, infants and children with cystic fibrosis.

Authors:  Marie-Claire Desax; Roland A Ammann; Jürg Hammer; Martin H Schoeni; Jürg Barben
Journal:  Eur J Pediatr       Date:  2007-04-14       Impact factor: 3.183

6.  Comparison of quantitative sweat chloride methods after positive newborn screen for cystic fibrosis.

Authors:  Theresa A Laguna; Nan Lin; Qi Wang; Bonnie Holme; John McNamara; Warren E Regelmann
Journal:  Pediatr Pulmonol       Date:  2012-01-03

7.  Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening.

Authors:  Annette Vernooij-van Langen; Edward Dompeling; Jan-Bart Yntema; Bert Arets; Harm Tiddens; Gerard Loeber; Jeannette Dankert-Roelse
Journal:  Eur J Pediatr       Date:  2015-02-13       Impact factor: 3.183

Review 8.  Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials.

Authors:  Steven M Rowe; Frank Accurso; John P Clancy
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

9.  Sources of Variation in Sweat Chloride Measurements in Cystic Fibrosis.

Authors:  Joseph M Collaco; Scott M Blackman; Karen S Raraigh; Harriet Corvol; Johanna M Rommens; Rhonda G Pace; Pierre-Yves Boelle; John McGready; Patrick R Sosnay; Lisa J Strug; Michael R Knowles; Garry R Cutting
Journal:  Am J Respir Crit Care Med       Date:  2016-12-01       Impact factor: 21.405

10.  Lack of association between excretion of sorafenib in sweat and hand-foot skin reaction.

Authors:  Lokesh Jain; Erin R Gardner; William D Figg; Milica S Chernick; Heidi H Kong
Journal:  Pharmacotherapy       Date:  2010-01       Impact factor: 4.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.